Venture Houston 2018
Skip Content

10 July 2018

Dynacure rides funding wave to raise $55m

The biopharmaceutical company, which was co-founded by Ionis Pharmaceuticals, has secured funding in an Andera Partners-led round.

Author: Thierry Heles, editor, Global University Venturing

Dynacure, a France-based centronuclear myopathy therapy developer backed by biopharmaceutical company Ionis Pharmaceuticals, raised €47m ($55m) yesterday in a funding round led by private equity firm Andera Partners.